These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 4559017)

  • 1. British anti-lewisite (BAL), the classic heavy metal antidote.
    Oehme FW
    Clin Toxicol; 1972; 5(2):215-22. PubMed ID: 4559017
    [No Abstract]   [Full Text] [Related]  

  • 2. British anti-Lewisite (dimercaprol): an amazing history.
    Vilensky JA; Redman K
    Ann Emerg Med; 2003 Mar; 41(3):378-83. PubMed ID: 12605205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical efficacy of dimercapto-chelating agents against lewisite-induced skin lesions in SKH-1 hairless mice.
    Mouret S; Wartelle J; Emorine S; Bertoni M; Nguon N; Cléry-Barraud C; Dorandeu F; Boudry I
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):291-8. PubMed ID: 23806213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are we ready to replace dimercaprol (BAL) as an arsenic antidote?
    Mückter H; Liebl B; Reichl FX; Hunder G; Walther U; Fichtl B
    Hum Exp Toxicol; 1997 Aug; 16(8):460-5. PubMed ID: 9292286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic distribution in rabbits after Lewisite administration and treatment with British anti-Lewisite (BAL).
    Snider TH; Wientjes MG; Joiner RL; Fisher GL
    Fundam Appl Toxicol; 1990 Feb; 14(2):262-72. PubMed ID: 2318351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. British anti-lewisite; antidotal effects against therapeutic arsenicals.
    STOCKEN LA; THOMPSON RH; WHITTAKER VP
    Biochem J; 1947; 41(1):47-52. PubMed ID: 20287850
    [No Abstract]   [Full Text] [Related]  

  • 7. Massive arsenic poisoning--effect of hemodialysis and dimercaprol on arsenic kinetics.
    Mathieu D; Mathieu-Nolf M; Germain-Alonso M; Neviere R; Furon D; Wattel F
    Intensive Care Med; 1992; 18(1):47-50. PubMed ID: 1578049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological chelation: 2,3-dimercapto-propanesulfonic acid and meso-dimercaptosuccinic acid.
    Aposhian HV
    Adv Enzyme Regul; 1982; 20():301-19. PubMed ID: 6287818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the efficacy of dimercapto chelating agents for the treatment of systemic organic arsenic poisoning in rabbits.
    Inns RH; Rice P; Bright JE; Marrs TC
    Hum Exp Toxicol; 1990 Jul; 9(4):215-20. PubMed ID: 2167707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. British anti-lewisite; arsenic and thiol excretion in animals after treatment of lewisite burns.
    STOCKEN LA; THOMPSON RH
    Biochem J; 1946 Jul; 40(4):548-54. PubMed ID: 20273640
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of dimercapto chelating agents for the treatment of poisoning by percutaneously applied dichloro(2-chlorovinyl)arsine in rabbits.
    Inns RH; Rice P
    Hum Exp Toxicol; 1993 May; 12(3):241-6. PubMed ID: 8100435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-lewisite activity and stability of meso-dimercaptosuccinic acid and 2,3-dimercapto-1-propanesulfonic acid.
    Aposhian HV; Mershon MM; Brinkley FB; Hsu CA; Hackley BE
    Life Sci; 1982 Nov; 31(19):2149-56. PubMed ID: 6294430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic poisoning in livestock.
    el Bahri L; Ben Romdane S
    Vet Hum Toxicol; 1991 Jun; 33(3):259-64. PubMed ID: 1858306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Excretion of arsenic in human urine after treatment with BAL].
    Geldmacher-von Mallinck ; Schütz W; Pétenyi M; Wolf R
    Beitr Gerichtl Med; 1973; 30():108-16. PubMed ID: 4702736
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of various antidotes on the biliary and intestinal excretion of arsenic in situ and into the feces in vivo in guinea-pigs after injection of As2O3.
    Reichl FX; Kreppel H; Szinicz L; Mückter H; Fichtl B; Forth W
    Arch Toxicol; 1994; 69(1):35-8. PubMed ID: 7536408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,3-Dithioerythritol, a possible new arsenic antidote.
    Boyd VL; Harbell JW; O'Connor RJ; McGown EL
    Chem Res Toxicol; 1989; 2(5):301-6. PubMed ID: 2562424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. British anti-Lewisite. III. Developments and applications.
    PETERS RA
    J R Inst Public Health; 1952 Jun; 15(6):151-67. PubMed ID: 14939268
    [No Abstract]   [Full Text] [Related]  

  • 18. British anti-Lewisite. II. Dithiols as antidotes.
    PETERS RA
    J R Inst Public Health; 1952 May; 15(5):122-39. PubMed ID: 14918251
    [No Abstract]   [Full Text] [Related]  

  • 19. The pharmacology of 2,3-dimercaptosuccinic acid and its potential use in arsenic poisoning.
    Graziano JH; Cuccia D; Friedheim E
    J Pharmacol Exp Ther; 1978 Dec; 207(3):1051-5. PubMed ID: 215741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical uses of 2,2-dimercaptopropanol (BAL); the systemic treatment of experimental arsenic poisoning (mapharsen, lewisite, phenyl arsenoxide) with BAL.
    EAGLE H; MAGNUSON HJ; FLEISCHMAN R
    J Clin Invest; 1946 Jul; 25(4):451-66. PubMed ID: 21001620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.